Society for Maternal‐Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism—Updated 2026 Authors: Society for Maternal‐Fetal Medicine (SMFM), L. Carolina Martinez‐King, C. Andrew Combs, Douglas M. Montgomery, Lorraine E. Toner, Gary A. Dildy, SMFM Patient Safety and Quality Committee Published: 2026 ABSTRACT AbstractAmniotic fluid embolism is a rare syndrome characterized by sudden cardiorespiratory collapse during labor or soon after delivery. Because of its rarity, many obstetrical providers have no experience in managing amniotic fluid embolism and may therefore benefit from a cognitive aid such as a checklist. In 2021, the Society for Maternal‐Fetal Medicine published a sample checklist for the initial management of amniotic fluid embolism based on standard management guidelines. In this article, we present an updated checklist with revisions to align the terminology with advanced cardiac life support guidelines. We also suggest steps that each facility can take to implement the checklist effectively. This Special Statement replaces Society for Maternal‐Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism, 2021. INTRODUCTION The year 2026 marks the 100th anniversary of the first published report of amniotic fluid embolism (AFE) [1]. AFE is a rare syndrome characterized by sudden cardiorespiratory collapse during labor or within 30 min after delivery of the placenta [2]. It is clinically diagnosed by cardiopulmonary arrest or hypotension with respiratory compromise, overt disseminated intravascular coagulation (DIC), and the absence of fever [3]. The syndrome is believed to be triggered by the abnormal release of trophoblasts or other material into the maternal circulation [4]. Despite its name, AFE likely has no direct relation to either amniotic fluid or an embolism [4, 5]. The reported incidence is about two to six cases per 100,000 births, and the case fatality rate ranges from about 20% to 40% or more in “classic” cases characterized by cardiovascular collapse and coagulopathy [4, 6]. Because of its rarity, many obstetrical providers have no experience in managing AFE, and many facilities will encounter only one or two cases per decade. When faced with a catastrophic, unfamiliar emergency, providers often find it difficult to think clearly or to recall the steps for the appropriate management. The result may be panic, confusion, chaos, poor communication and coordination among providers, and a suboptimal patient outcome. Priorities for pregnant people in cardiac arrest should include the provision of high‐quality cardiopulmonary resuscitation (CPR) and relief of aortocaval compression with lateral uterine displacement [7]. The management of AFE can benefit greatly from a cognitive aid such as a checklist, particularly during the initial, time‐critical response. In 2021, the Society for Maternal‐Fetal Medicine (SMFM) published a sample checklist for the initial management of AFE [8] that was based on an SMFM Clinical Guideline [3], a recent expert review [9], and a hospital system management flowchart [10]. We also outlined practical steps facilities can use to support effective implementation. SMFM now presents an updated checklist that incorporates revised terminology and clinical intervention criteria and better aligns with advanced cardiac life support guidance [10]. The update also integrates recent advances in understanding AFE epidemiology [5] and pathophysiology [11, 12]. CHECKLIST AND FLOW CHART A sample checklist is presented in Figure 1. It is intentionally focused on the immediate management of AFE on the labor and delivery (L&D) unit, where rapid response is essential. Post‐stabilization management after patient transfer to the intensive care unit (ICU), when there is typically more time for review and multidisciplinary discussion, is outside the scope of this document. Amniotic fluid embolism (AFE) checklist for initial management. CPR, cardiopulmonary resuscitation; DIC, disseminated intravascular coagulation; ECMO, extracorporeal membrane oxygenation; ROSC, return of spontaneous circulation. [Correction added 28 August 2026, after first online publication: the dosage units for norepinephrine, dobutamine, and milrinone have been updated to mcg/kg/min in Figure 1.] Our core design objective was a concise, low‐clutter checklist. We therefore removed routine early resuscitation actions that are standard practice and unlikely to be omitted (e.g., calling for help and initiating a code response, starting 100% oxygen, obtaining intravenous access, and providing ventilation with bag‐mask support or endotracheal intubation). Standard checklist design conventions were applied, including sans‐serif typography, restrained color use, and a clearly displayed version date. The checklist is formatted as a single page for printing on 8.5 × 11‐inch paper. We also present a sample flow chart summarizing the steps in the checklist as an alternative to the text‐based checklist (Figure 2). Management of cardiac arrest due to AFE. Note that the sequence may vary by individual case and available resources. AFE, amniotic fluid embolism; CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; MFM, maternal‐fetal medicine specialist; NICU, neonatal intensive care unit; NO, nitric oxide; ob‐gyn, obstetrician‐gynecologist; ROSC, return of spontaneous circulation; ROTEM, rotational thromboelastometry; TEG, thromboelastography. We prioritized creating content targeted to clinicians typically present at the bedside (e.g., obstetricians, anesthesiologists, and L&D nurses) rather than coordinating actions across hospital services (e.g., blood bank, pharmacy, rapid‐response team, and ICU staff). A broader, institution‐wide response algorithm is available elsewhere [10]. The differential diagnosis of AFE includes pulmonary embolism, myocardial infarction, air embolism, high spinal block, and sepsis. The initial management of all these conditions focuses on the same “ABC” principle: support of airway, breathing, and circulation. The clinical finding that will usually confirm the diagnosis of an AFE is the rapid appearance of DIC [4]. Cardiac arrest accompanies many cases of AFE, but not all [3]. Institutions may find it too complex to combine a detailed cardiac arrest checklist with an AFE checklist. Therefore, the AFE checklist focuses on the management of AFE after the patient has been resuscitated following cardiac arrest; it includes only rudimentary guidance regarding resuscitation, primarily to remind the care team that a cesarean delivery should be started within 4 min of maternal cardiac arrest if the maternal circulation has not been restored. It is assumed that initial basic life support will be started by a nurse or other provider, with transition to advanced cardiac life support once appropriately trained personnel and resources arrive. Because comprehensive cardiac arrest management in pregnancy involves additional protocol‐specific decisions (e.g., defibrillation timing and intervals and medication dose and route), it is outside the scope of this checklist. Facilities should therefore maintain a separate pregnancy‐specific cardiac arrest flowsheet or checklist; high‐quality examples are provided in the American Heart Association Scientific Statement on cardiac arrest in pregnancy [13]. Immediate delivery can improve maternal hemodynamics and, in a patient receiving CPR, should be initiated within 4 min to increase the likelihood of return of spontaneous circulation [9, 13]. Operative vaginal delivery can be considered if the cervix is completely dilated and the fetal head is crowning; otherwise, a trial of operative vaginal delivery is likely to unnecessarily delay delivery compared with immediate cesarean delivery. The term “resuscitative hysterotomy” is gaining acceptance as a replacement for the term “perimortem cesarean delivery” to reflect the potential maternal benefits of the procedure more accurately [14]. Although performing a cesarean delivery during maternal cardiac arrest can pose technical challenges, this life‐saving intervention should not be delayed: perform the cesarean delivery wherever the patient is located, and do not delay by moving to the operating room. Transfer to the operating room should be considered only if it can be accomplished within 1 to 2 min. Once the newborn is delivered, the obstetrical care provider's attention should be directed toward preventing and managing hemorrhage and DIC. In the section of the checklist titled “Anticipate uterine atony, DIC, and hemorrhage,” we remind clinicians to be prepared for these complications and suggest steps that may reduce morbidity, including the use of uterotonic agents, administration of tranexamic acid [15], and initiation of the hospital's massive transfusion protocol. DIC accompanies more than 80% of AFE cases [3]. Standard massive transfusion protocols call for the replacement of packed red blood cells, platelets, and plasma in an approximately 1:1:1 ratio; however, in AFE, cryoprecipitate is favored over fresh or frozen plasma to limit the risk of volume overload while addressing coagulopathy [9]. We cannot overstate the importance of clearly assigning roles for timekeeping and for documenting blood‐product administration during massive transfusion protocol activation. In the checklist section “Manage pulmonary hypertension and right ventricular failure (anesthesiology, critical care, or cardiology),” we focus on the pulmonary hypertension and right ventricular dysfunction that commonly characterize AFE [3, 9, 12] and provide targeted guidance on inotrope selection and afterload‐reducing agents. The anesthesiology team typically directs airway management, ventilation strategy, fluid titration, and broader pharmacotherapy; these tasks are not explicitly itemized because they are standard components of anesthetic practice and unlikely to be omitted by an experienced provider. For hemodynamically refractory cases, extracorporeal membrane oxygenation can be considered, even in the context of coagulopathy [9]. In a systematic review of 79 cases, extracorporeal membrane oxygenation was associated with 72% maternal survival and a 6% incidence of major neurologic sequelae [16]. Avoidance of fluid overload is an important management principle of pulmonary hypertension and right heart failure. We recommend using blood products for volume resuscitation rather than crystalloid or colloid fluids. Inotropes and pulmonary vasodilators are the primary therapies; transthoracic or transesophageal echocardiography can be used to guide therapy. A regimen of atropine, ondansetron, and ketorolac has been suggested as a potential therapy for AFE. However, evidence for this regimen is limited to case reports. Potential harms include worsening of kidney function, bleeding coagulopathy, cardiac arrhythmia, and myocardial injury [17]. The American Heart Association [18] recommends against the use of atropine in the absence of bradycardia, and a panel of experts [17] recommends against the routine use of the atropine, ondansetron, and ketorolac regimen. Debriefing is recommended soon after transfer to the ICU or, if the patient dies, as soon as feasible. The purpose of the debrief is to discuss which aspects of the care were well managed and to identify the areas in which systems or processes should be improved. In addition, the need for psychological and emotional support for the patient, family members, and clinical staff should be recognized. Patient‐ and family‐support resources are available in the National Partnership for Maternal Safety consensus bundle, Support After a Severe Maternal Event [19], and additional materials are provided by the AFE Foundation [20]. Healthcare providers may also experience “second victim” trauma after adverse events; therefore, it is important to address their needs as well [21]. Finally, we recommend submitting all suspected AFE cases to the AFE Foundation's international registry [22]. Registry‐based reports have generated important data on risk factors, clinical correlates [23], and outcomes [24], and future analyses may identify management strategies associated with improved survival and neurologic outcomes. Comprehensive reporting, including cases with poor outcomes, is essential to maximize the registry's value. SUGGESTIONS FOR IMPLEMENTATION The sample checklist is presented as general guidance and shows a practical approach for the initial stabilization and management of a patient with an AFE. Individual facilities should modify and adapt it to fit their unique attributes. These attributes may include whether the facility has trainees (e.g., residents, medical students, or nursing students), 24‐h in‐house anesthesia coverage, a hospital‐wide rapid‐response team, an in‐house blood bank, and several other facility‐specific considerations. The optimal implementation of the checklist requires several steps, which we encourage each facility to follow. Additional guidance on these steps is covered in overviews regarding the development and implementation of checklists [25, 26]. Suggested steps include the following: Assemble a multidisciplinary team to review the checklist and make modifications to fit facility‐specific requirements. A relevant stakeholder group will most likely include obstetrical providers (e.g., generalists, hospitalists, and maternal‐fetal medicine subspecialists); obstetrical anesthesia providers (e.g., anesthesiologists and nurse anesthetists); L&D nursing leadership and staff; medicine subspecialists (e.g., cardiology, pulmonary, and critical care); and representatives of the blood bank, pharmacy, rapid response team, and emergency department. Each stakeholder group should have at least one member on the team.Decide where the checklist should be kept. Almost all AFE cases occur in the labor room, delivery room, operating room, or the post‐anesthesia recovery unit. It is likely impractical to post the checklist on a wall in every relevant room. A likely place to keep it would be in a pocket on the side of the “crash cart” or “hemorrhage cart” in the L&D unit. Units with a readily accessible computerized system for storing and accessing such material may consider keeping the checklist there.Conduct a pilot test of the checklist by having the development team run through simulated scenarios. Identify problem items and make modifications as needed to address them. After revision of the checklist, conduct another pilot test.Introduce the checklist broadly. Once the finalized checklist is in place, communicate to all the relevant clinical staff (e.g., obstetrical providers, obstetrical anesthesiologists, and L&D nurses) where it is kept. Review the contents of the checklist during nursing in‐service training, grand rounds, and obstetrics and anesthesia departmental meetings. Discuss it at board reports and during change‐of‐shift huddles to improve awareness.Run simulations and drills of AFE scenarios to familiarize all the relevant staff with the location of the checklist and to give them practice in using it to guide the execution of the interventions.Conduct a sentinel event analysis after each AFE case. Identify systems or processes that can be improved, such as delays involving medications, blood products, or personnel. Discuss any changes needed to improve the checklist contents or location.Consider developing institutional performance measures (e.g., percentage of suspected AFE events in which the SMFM AFE checklist is initiated and documented, time from AFE recognition to CPR initiation and to cesarean delivery, or mean documentation time during codes before versus after checklist implementation). Assemble a multidisciplinary team to review the checklist and make modifications to fit facility‐specific requirements. A relevant stakeholder group will most likely include obstetrical providers (e.g., generalists, hospitalists, and maternal‐fetal medicine subspecialists); obstetrical anesthesia providers (e.g., anesthesiologists and nurse anesthetists); L&D nursing leadership and staff; medicine subspecialists (e.g., cardiology, pulmonary, and critical care); and representatives of the blood bank, pharmacy, rapid response team, and emergency department. Each stakeholder group should have at least one member on the team. Assemble a multidisciplinary team to review the checklist and make modifications to fit facility‐specific requirements. A relevant stakeholder group will most likely include obstetrical providers (e.g., generalists, hospitalists, and maternal‐fetal medicine subspecialists); obstetrical anesthesia providers (e.g., anesthesiologists and nurse anesthetists); L&D nursing leadership and staff; medicine subspecialists (e.g., cardiology, pulmonary, and critical care); and representatives of the blood bank, pharmacy, rapid response team, and emergency department. Each stakeholder group should have at least one member on the team. Decide where the checklist should be kept. Almost all AFE cases occur in the labor room, delivery room, operating room, or the post‐anesthesia recovery unit. It is likely impractical to post the checklist on a wall in every relevant room. A likely place to keep it would be in a pocket on the side of the “crash cart” or “hemorrhage cart” in the L&D unit. Units with a readily accessible computerized system for storing and accessing such material may consider keeping the checklist there. Decide where the checklist should be kept. Almost all AFE cases occur in the labor room, delivery room, operating room, or the post‐anesthesia recovery unit. It is likely impractical to post the checklist on a wall in every relevant room. A likely place to keep it would be in a pocket on the side of the “crash cart” or “hemorrhage cart” in the L&D unit. Units with a readily accessible computerized system for storing and accessing such material may consider keeping the checklist there. Conduct a pilot test of the checklist by having the development team run through simulated scenarios. Identify problem items and make modifications as needed to address them. After revision of the checklist, conduct another pilot test. Conduct a pilot test of the checklist by having the development team run through simulated scenarios. Identify problem items and make modifications as needed to address them. After revision of the checklist, conduct another pilot test. Introduce the checklist broadly. Once the finalized checklist is in place, communicate to all the relevant clinical staff (e.g., obstetrical providers, obstetrical anesthesiologists, and L&D nurses) where it is kept. Review the contents of the checklist during nursing in‐service training, grand rounds, and obstetrics and anesthesia departmental meetings. Discuss it at board reports and during change‐of‐shift huddles to improve awareness. Introduce the checklist broadly. Once the finalized checklist is in place, communicate to all the relevant clinical staff (e.g., obstetrical providers, obstetrical anesthesiologists, and L&D nurses) where it is kept. Review the contents of the checklist during nursing in‐service training, grand rounds, and obstetrics and anesthesia departmental meetings. Discuss it at board reports and during change‐of‐shift huddles to improve awareness. Run simulations and drills of AFE scenarios to familiarize all the relevant staff with the location of the checklist and to give them practice in using it to guide the execution of the interventions. Run simulations and drills of AFE scenarios to familiarize all the relevant staff with the location of the checklist and to give them practice in using it to guide the execution of the interventions. Conduct a sentinel event analysis after each AFE case. Identify systems or processes that can be improved, such as delays involving medications, blood products, or personnel. Discuss any changes needed to improve the checklist contents or location. Conduct a sentinel event analysis after each AFE case. Identify systems or processes that can be improved, such as delays involving medications, blood products, or personnel. Discuss any changes needed to improve the checklist contents or location. Consider developing institutional performance measures (e.g., percentage of suspected AFE events in which the SMFM AFE checklist is initiated and documented, time from AFE recognition to CPR initiation and to cesarean delivery, or mean documentation time during codes before versus after checklist implementation). Consider developing institutional performance measures (e.g., percentage of suspected AFE events in which the SMFM AFE checklist is initiated and documented, time from AFE recognition to CPR initiation and to cesarean delivery, or mean documentation time during codes before versus after checklist implementation). Use of a readily available checklist by providers who have practiced using it should result in a coordinated, controlled response to an AFE and improve outcomes by ensuring that patients who experience this rare, catastrophic event receive timely and optimal care. The use of this information is voluntary, and clinicians should be familiar with and comply with all applicable laws and regulations.All authors and committee members have filed a disclosure of interests delineating personal, professional, business, or other relevant financial or nonfinancial interests in relation to this publication. Any substantial conflicts of interest have been addressed through a process approved by the Society for Maternal‐Fetal Medicine (SMFM) Board of Directors. SMFM has neither solicited nor accepted any commercial involvement in the specific content development of this publication.This document has undergone an internal peer review through a multilevel committee process within SMFM. This review involves critique and feedback from the SMFM Patient Safety and Quality Committee and Document Review Committee and final approval by the SMFM Executive Committee. SMFM accepts sole responsibility for the document content. SMFM publications do not undergo editorial and peer review by Pregnancy. The SMFM Patient Safety and Quality Committee reviews publications every 24 to 36 months and issues updates as needed. Further details regarding SMFM publications can be found at smfm.org/publications.SMFM recognizes that obstetrical patients have diverse gender identities and strives to use gender‐inclusive language in all publications. SMFM uses terms such as “pregnant person” and “pregnant individual” and the singular pronoun “they.” When describing study populations used in research, SMFM uses the terminology reported by the study investigators.All questions or comments regarding the document should be referred to pubs@smfm.org.Reprints will not be available. The use of this information is voluntary, and clinicians should be familiar with and comply with all applicable laws and regulations. All authors and committee members have filed a disclosure of interests delineating personal, professional, business, or other relevant financial or nonfinancial interests in relation to this publication. Any substantial conflicts of interest have been addressed through a process approved by the Society for Maternal‐Fetal Medicine (SMFM) Board of Directors. SMFM has neither solicited nor accepted any commercial involvement in the specific content development of this publication. This document has undergone an internal peer review through a multilevel committee process within SMFM. This review involves critique and feedback from the SMFM Patient Safety and Quality Committee and Document Review Committee and final approval by the SMFM Executive Committee. SMFM accepts sole responsibility for the document content. SMFM publications do not undergo editorial and peer review by Pregnancy. The SMFM Patient Safety and Quality Committee reviews publications every 24 to 36 months and issues updates as needed. Further details regarding SMFM publications can be found at smfm.org/publications. SMFM recognizes that obstetrical patients have diverse gender identities and strives to use gender‐inclusive language in all publications. SMFM uses terms such as “pregnant person” and “pregnant individual” and the singular pronoun “they.” When describing study populations used in research, SMFM uses the terminology reported by the study investigators. All questions or comments regarding the document should be referred to pubs@smfm.org. Reprints will not be available.